About Christopher Pacheco
Form D filings for Aakha Biologics in 2024 list Christopher Pacheco as director.
Christopher Pacheco first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher Pacheco in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Christopher Pacheco works with at each company, as listed on that company's latest Form D.
Aakha Biologics, Inc. · Form D, Jul 17, 2024
